Pembrolizumab/Axitinib and Avelumab/Axitinib combo for RCC VJOncology 1:00 5 years ago 220 Скачать Далее
Dr. Rini on the Efficacy of Axitinib and Pembrolizumab in RCC OncLive 1:19 7 years ago 658 Скачать Далее
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC OncLive 1:17 3 years ago 812 Скачать Далее
Exciting potential of pembrolizumab combined with axitinib for kidney cancer VJOncology 1:06 5 years ago 287 Скачать Далее
Overview of a Phase III Trial of Pembrolizumab Plus Axitinib in RCC Targeted Oncology 2:23 7 years ago 524 Скачать Далее
Dr Rini on a Biomarker Analysis for Pembrolizumab/Axitinib in Advanced RCC OncLive 3:28 1 month ago 39 Скачать Далее
Dr. Cost on Pembrolizumab Plus Axitinib in Patients With RCC OncLive 1:56 7 years ago 378 Скачать Далее
Promising results for axitinib and pembrolizumab in advanced renal cell cancer VJOncology 3:30 5 years ago 2 112 Скачать Далее
KEYNOTE-426 rationale and results: pembro plus axitinib vs. sunitinib in mRCC VJOncology 3:10 5 years ago 469 Скачать Далее
Pembrolizumab Plus Axitinib in the Second-line and Beyond for mRCC GU Oncology Now 4:40 1 year ago 76 Скачать Далее
Real-world treatment outcomes of 1L axitinib + pembrolizumab in patients with advanced RCC in the US VJOncology 5:10 2 years ago 1 052 Скачать Далее
Dr. Rini on Managing the Toxicity of Pembrolizumab Plus Axitinib in mRCC OncLive 1:03 5 years ago 700 Скачать Далее
Kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo VJOncology 4:25 5 years ago 552 Скачать Далее
Dr. Powles on FDA Approval of Pembrolizumab Plus Axitinib in Advanced RCC OncLive 1:40 5 years ago 235 Скачать Далее
Dr. McGregor on Implications of the FDA Approval of Pembrolizumab/Axitinib in RCC OncLive 2:02 5 years ago 212 Скачать Далее
KEYNOTE-426 - Pembrolizumab plus axitinib versus sunitinib for mRCC VJOncology 4:47 4 years ago 443 Скачать Далее
